RxDoctor Payments Data

Molly Sharp, PA

Physician Assistant · Roanoke, VANPI 1922257088

Payments from drug & device makers

$5,116in general payments, 2019–2025

Across 326 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • AbbVie$967
  • Lundbeck LLC$840
  • Alkermes, Inc.$384
  • Otsuka America Pharmaceutical, Inc.$315
  • Neurocrine Biosciences, Inc.$289
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$4,80894%
  • Education$3086%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,116 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$29,502
Medicare patients
70
Services billed
281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole38$71,695
VraylarCariprazine Hcl30$40,515
LatudaLurasidone Hcl20$37,831
Lurasidone Hcl60$29,361
Aripiprazole109$18,924
TrintellixVortioxetine Hydrobromide36$17,347
VyvanseLisdexamfetamine Dimesylate25$9,349
Ziprasidone Hcl84$3,678
Chlorpromazine Hcl17$2,870
Buspirone Hcl183$2,818
Lamotrigine298$2,784
Quetiapine Fumarate ErQuetiapine Fumarate62$2,329
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate11$2,102
Bupropion XlBupropion Hcl162$2,038
Quetiapine Fumarate207$1,964

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$315$71,69538 claims
AbbVieVraylar$967$40,51530 claims
Sunovion Pharmaceuticals Inc.Latuda$37$37,83120 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$157$26,69661 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →